BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohammadian M, Zeynali-Moghaddam S, Khadem Ansari MH, Rasmi Y, Fathi Azarbayjani A, Kheradmand F. Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine. Adv Pharm Bull 2019;9:439-44. [PMID: 31592113 DOI: 10.15171/apb.2019.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadian M, Feizollahzadeh S, Mahmoudi R, Toofani Milani A, Rezapour-Firouzi S, Karimi Douna B. Hsp90 Inhibitor; NVP-AUY922 in Combination with Doxorubicin Induces Apoptosis and Downregulates VEGF in MCF-7 Breast Cancer Cell Line. Asian Pac J Cancer Prev 2020;21:1773-8. [PMID: 32592377 DOI: 10.31557/APJCP.2020.21.6.1773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liao Y, Yang Y, Pan D, Ding Y, Zhang H, Ye Y, Li J, Zhao L. HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia. Cancers (Basel) 2021;13:E243. [PMID: 33440739 DOI: 10.3390/cancers13020243] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Dalvand S, Namdari A, Sepahvand F, Meshkibaf MH, Ahmadpour G. Investigation of Decitabine Effects on HDAC3 and HDAC7 mRNA Expression in NALM-6 and HL-60 Cancer Cell Lines. Rep Biochem Mol Biol 2021;10:420-8. [PMID: 34981019 DOI: 10.52547/rbmb.10.3.420] [Reference Citation Analysis]
4 Taghvaei F, Rastin SJ, Milani AT, Khameneh ZR, Hamini F, Rasouli MA, Asghari K, Rekabi Shishavan AM, Ebrahimifar M, Rashidi S. Carboplatin and epigallocatechin-3-gallate synergistically induce cytotoxic effects in esophageal cancer cells. Res Pharm Sci 2021;16:240-9. [PMID: 34221057 DOI: 10.4103/1735-5362.314822] [Reference Citation Analysis]
5 Esgandari K, Mohammadian M, Zohdiaghdam R, Rastin SJ, Alidadi S, Behrouzkia Z. Combined treatment with silver graphene quantum dot, radiation, and 17-AAG induces anticancer effects in breast cancer cells. J Cell Physiol 2021;236:2817-28. [PMID: 32901933 DOI: 10.1002/jcp.30046] [Reference Citation Analysis]